natlawreview.com
/1 month ago
Latest updates for Ben Hertz-Shargel
Fresh curated links around Ben Hertz-Shargel are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Practical Guidance for Pharmaceutical Method-of-Use Patent Claims After Teva v. Eli Lilly and In re Xencor
- Sunshine Guojian Releases 2026 Interim Report:
- Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
qchron.com
/2 weeks ago
Sunshine Guojian Releases 2026 Interim Report:
Innovation-driven, Steady Advancement
fiercebiotech.com
/4 weeks ago
Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
Three years after Robert Hoffman sold XinThera to Gilead, the veteran Pfizer chemist has unveiled his latest venture.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Ben Hertz-Shargel
natlawreview.com
Recent coverage from public sources
Public source
fiercebiotech.com
Recent coverage from public sources
Public source
qchron.com
Recent coverage from public sources
Public source